| Identification | Back Directory | [Name]
Carbamic acid, 3-azabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester, | [CAS]
134575-17-0 | [Synonyms]
113909
MN-2633
CP-101537
PF-3339644
exo-6-(Boc-amino)-3-azabi...
6-(BOC-AMINO)-3-AZABICYCLO[3.1.0]HEXANE
exo-6-(Boc-amino)-3-azabicyclo[3.1.0]hexane
TERT-BUTYL MESO-3-AZABICYCLO[3.1.0]HEX-6-YLCARBAMATE
tert-butyl N-(3-azabicyclo[3.1.0]hexan-6-yl)carbaMate
(1R,5S,6s)-rel-6-(Boc-amino)-3-azabicyclo[3.1.0]hexane
rac(tert-butyl N-[3-azabicyclo[3.1.0]hexan-6-yl]carbamate
tert-butyl N-[exo-3-azabicyclo[3.1.0]hexan-6-yl]carbamate
tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hexan-6-ylcarbamate
tert-butyl (1R,5S,6s)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
tert-butyl (1R,5S,6s)-3-azabicyclo[3.1.0]hexan-6-ylcarbaMate
tert-butyl N-[(1S,5R)-3-Azabicyclo[3.1.0]hexan-6-yl]carbaMate
(1à,5à,6à)-6-tert-Butoxycarbonylamino-3-azabicyclo[3.1.0]-hexane
Tert-Butyl (Meso-1R,5S,6S)-3-Azabicyclo[3.1.0]Hexan-6-Ylcarbamate
tert-butyl N-[rel-(1R,5S,6r)-3-azabicyclo[3.1.0]hexan-6-yl]carbamate
Carbamic acid, 3-azabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester,
N-(1a,5a,6a)-3-azabicyclo[3.1.0]hex-6-yl-carbaMic Acid 1,1-DiMethylethyl Ester
N-(1α,5α,6α)-3-Αzabicyclo[3.1.0]hex-6-yl-carbaMic Acid 1,1-DiMethylethyl Ester
CarbaMic acid, 3-azabicyclo[3.1.0]hex-6-yl-, 1,1-diMethylethyl ester, (1a,5a,6a)-
Carbamic acid, N-(1α,5α,6α)-3-azabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester | [EINECS(EC#)]
429-170-8 | [Molecular Formula]
C10H18N2O2 | [MDL Number]
MFCD12198677 | [MOL File]
134575-17-0.mol | [Molecular Weight]
198.262 |
| Chemical Properties | Back Directory | [Melting point ]
110-111°C | [Boiling point ]
305.3±31.0 °C(Predicted) | [density ]
1.11±0.1 g/cm3(Predicted) | [storage temp. ]
-20?C Freezer | [solubility ]
DMSO: >20mg/mL | [form ]
powder | [pka]
12.39±0.20(Predicted) | [color ]
white to off-white |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White to Pale Yellow Solid | [Uses]
An intermediate of Trovafloxacin (T893000) and analogs. | [Biochem/physiol Actions]
CP-101537 is a MMP inhibitor, candidate drug for myocardial infarction therapy, and antibacterial. |
|
|